DIgitAl diabeTES Treatment - the Healthy Eating, heaLthy Patients Trial
- Conditions
- Type 2 Diabetes
- Interventions
- Other: FoodSwitch
- Registration Number
- NCT05977218
- Lead Sponsor
- Linkoeping University
- Brief Summary
Unhealthy diet is a major target in the prevention and treatment of type 2 diabetes (T2D) but access to dieticians in primary care is limited. While mobile health (mHealth) tools have been shown to improve diet and clinical management of patients with T2D, there are currently no such mHealth tools for patients with T2D in Sweden. The key limitation of existing mHealth tools is that they provide generic dietary advice that is often difficult to implement in practice (e.g., non-specific suggestions to choose low-sugar products). The George Institute for Global Health (Sydney, Australia) as developed the FoodSwitch mobile phone application (app), which suggests healthier food choices to consumers after scanning of packaged food items in the grocery store. In the DIgitAl diabeTES Treatment - the Healthy Eating, heaLthy Patients trial (DIATEST-HELP), we will adapt the FoodSwitch app for use in Sweden, and study the effect on glycated haemoglobin (HbA1c), blood lipids, and low-grade inflammation in individuals with T2D using a randomized controlled trial design.
- Detailed Description
Unhealthy diet is a major target in the prevention and treatment of type 2 diabetes (T2D) but access to dieticians in primary care is limited. While mobile health (mHealth) tools have been shown to improve diet and clinical management of patients with T2D, there are currently no such mHealth tools for patients with T2D in Sweden. The key limitation of existing mHealth tools is that they provide generic dietary advice that is often difficult to implement in practice (e.g., non-specific suggestions to choose low-sugar products). The George Institute for Global Health (Sydney, Australia) as developed the FoodSwitch mobile phone application (app), which suggests healthier food choices to consumers after scanning of packaged food items in the grocery store. In the DIgitAl diabeTES Treatment - the Healthy Eating, heaLthy Patients trial (DIATEST-HELP), we will adapt the FoodSwitch app for use in Sweden, and study the effect on glycated haemoglobin (HbA1c), blood lipids, and low-grade inflammation in individuals with T2D using a randomized controlled trial design.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 900
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intervention FoodSwitch Access to the 'DiabetesSwitch' filter of the FoodSwitch app when food shopping during 26 weeks.
- Primary Outcome Measures
Name Time Method HbA1c (mmol/mol) Change from baseline at week 26 Hemoglobin A1C (mmol/mol)
- Secondary Outcome Measures
Name Time Method Total cholesterol (mmol/l) Change from baseline at week 26 Total cholesterol (mmol/l)
LDL (mmol/l) Change from baseline at week 26 Low-density lipoprotein (mmol/l)
HDL (mmol/l) Change from baseline at week 26 High-density lipoprotein (mmol/l)
Proteomics, and metabolomics Change from baseline at week 26 The analysis of proteomics and metabolomics is explorative, and therefore the selection of proteins and metabolites is not pre-determined but will rather include those that are available and deemed appropriate at the time of analysis
Self-measured waist circumference (cm) Change from baseline at week 26 Self-measured waist circumference (cm)
Self-reported quality of life Change from baseline at week 26 Self-reported quality of life - questionnaire
Self-measured body weight (kg) Change from baseline at week 26 Self-measured body weight (kg)